ACETAMINOPHEN AND CODEINE

ACETAMINOPHEN AND CODEINE was reported 12266 times

ACETAMINOPHEN AND CODEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GANGRENE NEONATAL 7 0.5833
1 THIOPURINE METHYLTRANSFERASE DECREASED 11 0.3235
2 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
3 HEPATIC ENZYME 43 0.2886
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 145 0.2585
5 FACET JOINT SYNDROME 806 0.2473
6 VAGINAL FLATULENCE 67 0.2211
7 DUODENAL ULCER PERFORATION 1527 0.2051
8 COMPUTERISED TOMOGRAM THORAX 12 0.2000
9 C-REACTIVE PROTEIN 185 0.1996
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 390 0.1947
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 403 0.1943
12 X-RAY ABNORMAL 345 0.1927
13 SWOLLEN JOINT COUNT 48 0.1920
14 RHEUMATIC FEVER 849 0.1903
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1361 0.1898
16 SWOLLEN JOINT COUNT INCREASED 563 0.1764
17 LUPUS VULGARIS 220 0.1746
18 DISLOCATION OF VERTEBRA 395 0.1730
19 GRIP STRENGTH 39 0.1703
20 PERIPHERAL VENOUS DISEASE 696 0.1703
21 MUSCLE INJURY 1359 0.1639
22 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 108 0.1617
23 HELICOBACTER INFECTION 1518 0.1476
24 HYPOCHOLESTEROLAEMIA 51 0.1445
25 FOLLICULITIS 1469 0.1399
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 850 0.1307
27 RHEUMATOID FACTOR POSITIVE 699 0.1209
28 PEMPHIGUS 1461 0.1167
29 BREAST CANCER STAGE III 731 0.1128
30 HAND DEFORMITY 1435 0.1093
31 RETINITIS 185 0.1070
32 VASCULAR MALFORMATION 22 0.1048
33 C-REACTIVE PROTEIN ABNORMAL 655 0.1020
34 PARANASAL CYST 22 0.0905
35 PERICARDITIS 1457 0.0866
36 PORPHYRIA ACUTE 123 0.0857
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 9 0.0857
38 LIP DRY 765 0.0841
39 BLEPHAROSPASM 527 0.0836
40 TENDER JOINT COUNT 7 0.0833
41 BURSITIS 981 0.0808
42 SYNOVITIS 1416 0.0785
43 ONYCHOMADESIS 314 0.0747
44 SPINAL FLATTENING 9 0.0732
45 HYPERCHOLESTEROLAEMIA 664 0.0687
46 JOINT RANGE OF MOTION DECREASED 911 0.0679
47 LIVE BIRTH 567 0.0677
48 WOUND INFECTION 739 0.0674
49 DEPENDENCE 3690 0.0672
50 GRIP STRENGTH DECREASED 568 0.0645
51 IRRITABLE BOWEL SYNDROME 1375 0.0641
52 INFUSION SITE REACTION 188 0.0629
53 GLOSSODYNIA 1407 0.0628
54 BONE EROSION 218 0.0616
55 JOINT LAXITY 17 0.0563
56 ANORECTAL POLYP 6 0.0561
57 SERONEGATIVE ARTHRITIS 62 0.0541
58 MATERNAL EXPOSURE TIMING UNSPECIFIED 200 0.0532
59 WOUND 1315 0.0470
60 NAIL DISORDER 401 0.0458
61 FIBROMYALGIA 1079 0.0443
62 VISION ABNORMAL NEONATAL 18 0.0431
63 PUSTULAR PSORIASIS 147 0.0428
64 IMPAIRED HEALING 1398 0.0425
65 OBESITY 676 0.0424
66 AUTOIMMUNE DISORDER 412 0.0422
67 SYSTEMIC LUPUS ERYTHEMATOSUS 1492 0.0420
68 LOOSE BODY IN JOINT 11 0.0414
69 FEMALE GENITAL TRACT FISTULA 70 0.0410
70 CREATININE RENAL CLEARANCE INCREASED 30 0.0401
71 CONTRAINDICATED PRODUCT ADMINISTERED 1174 0.0387
72 MULTIPLE DRUG THERAPY 29 0.0385
73 ONYCHOMYCOSIS 165 0.0376
74 DRUG TOLERANCE DECREASED 103 0.0366
75 LIVER INJURY 896 0.0365
76 COMPUTERISED TOMOGRAM THORAX ABNORMAL 25 0.0364
77 WEIGHT DECREASE NEONATAL 7 0.0361
78 SENSITISATION 27 0.0356
79 BACK INJURY 366 0.0336
80 FINGER DEFORMITY 160 0.0330
81 BREAST CANCER STAGE II 272 0.0327
82 MYELOCYTE COUNT INCREASED 6 0.0319
83 CARBUNCLE 9 0.0318
84 OVERLAP SYNDROME 22 0.0314
85 LOWER RESPIRATORY TRACT INFECTION 1422 0.0312
86 RASH VESICULAR 147 0.0304
87 WALKING AID USER 192 0.0291
88 PRODUCT LABEL CONFUSION 168 0.0288
89 SEDATION COMPLICATION 72 0.0282
90 TYPE 2 DIABETES MELLITUS 949 0.0282
91 ARTHROPATHY 1547 0.0278
92 BLISTER 1545 0.0275
93 BULIMIA NERVOSA 12 0.0273
94 MONOCYTE COUNT ABNORMAL 6 0.0270
95 ENTHESOPATHY 42 0.0268
96 EXOSTOSIS 245 0.0268
97 MASTOIDITIS 26 0.0265
98 RADICULOPATHY 69 0.0262
99 COELIAC DISEASE 255 0.0260
100 PSORIATIC ARTHROPATHY 1023 0.0252
101 STOMATITIS 1491 0.0246
102 CONGENITAL ANOMALY 190 0.0245
103 TEMPERATURE REGULATION DISORDER 54 0.0242
104 PROCTITIS 67 0.0239
105 THERAPEUTIC PRODUCT EFFECT DECREASED 1067 0.0238
106 SCIATICA 374 0.0234
107 RECTAL POLYP 23 0.0233
108 PRESCRIBED OVERDOSE 451 0.0233
109 SKIN TURGOR DECREASED 9 0.0232
110 NIGHT SWEATS 733 0.0227
111 INFUSION RELATED REACTION 1503 0.0227
112 HEPATIC ENZYME INCREASED 1533 0.0225
113 BLOOD CHOLESTEROL INCREASED 1047 0.0224
114 GAIT INABILITY 740 0.0221
115 TASTE DISORDER 445 0.0219
116 RED BLOOD CELL SEDIMENTATION RATE INCREASED 242 0.0218
117 LUPUS-LIKE SYNDROME 195 0.0215
118 LOWER LIMB FRACTURE 399 0.0207
119 OSTEOARTHRITIS 874 0.0206
120 PULMONARY FIBROSIS 391 0.0204
121 ILL-DEFINED DISORDER 1197 0.0197
122 DISCOMFORT 1199 0.0196
123 NORMAL NEWBORN 106 0.0195
124 EPILEPSY 571 0.0187
125 CREATININE RENAL CLEARANCE DECREASED 72 0.0180
126 GENERAL SYMPTOM 132 0.0176
127 MYOSITIS 152 0.0169
128 CHRONIC SINUSITIS 63 0.0168
129 PRODUCT USED FOR UNKNOWN INDICATION 21 0.0167
130 LIVER FUNCTION TEST INCREASED 358 0.0167
131 SPONDYLITIS 60 0.0165
132 C-REACTIVE PROTEIN INCREASED 592 0.0163
133 SWELLING 1485 0.0159
134 DRUG INTOLERANCE 1521 0.0157
135 WHEEZING 918 0.0155
136 INFLAMMATION 793 0.0153
137 TENOSYNOVITIS 42 0.0152
138 RHEUMATOID ARTHRITIS 1728 0.0152
139 MUSCULOSKELETAL PAIN 794 0.0151
140 PYROGLUTAMIC ACIDOSIS 6 0.0151
141 HIP ARTHROPLASTY 230 0.0150
142 LUNG DISORDER 731 0.0149
143 ULCER HAEMORRHAGE 100 0.0148
144 LEARNING DISABILITY 78 0.0146
145 FOOT DEFORMITY 158 0.0142
146 FRACTURE DELAYED UNION 12 0.0142
147 MOBILITY DECREASED 1004 0.0140
148 GASTROINTESTINAL DISORDER 1241 0.0138
149 INJURY 970 0.0138
150 CHANGE OF BOWEL HABIT 28 0.0136
151 DISABILITY 268 0.0135
152 MATERNAL EXPOSURE DURING PREGNANCY 1207 0.0135
153 JOINT SWELLING 1630 0.0135
154 PREGNANCY 269 0.0134
155 EYE INJURY 38 0.0125
156 JOINT DISLOCATION 132 0.0125
157 SLEEP DISORDER 869 0.0123
158 DELIRIUM 422 0.0121
159 HEPATIC CIRRHOSIS 227 0.0121
160 MONOCLONAL IMMUNOGLOBULIN PRESENT 9 0.0118
161 TREATMENT FAILURE 977 0.0118
162 JOINT DESTRUCTION 18 0.0116
163 POSTURING 6 0.0115
164 DRUG WITHDRAWAL SYNDROME NEONATAL 171 0.0115
165 OESOPHAGEAL SPASM 21 0.0114
166 WRIST DEFORMITY 7 0.0114
167 PRESCRIBED UNDERDOSE 224 0.0112
168 MUSCULOSKELETAL STIFFNESS 983 0.0112
169 OEDEMA 607 0.0112
170 FOETAL DEATH 58 0.0112
171 ADVERSE REACTION 148 0.0112
172 CONTUSION 1065 0.0111
173 THYROXINE FREE DECREASED 6 0.0106
174 DRY MOUTH 852 0.0105
175 KNEE ARTHROPLASTY 221 0.0105
176 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
177 DEVICE MAINTENANCE ISSUE 6 0.0102
178 DIARRHOEA INFECTIOUS 8 0.0102
179 ROAD TRAFFIC ACCIDENT 424 0.0101
180 CONFUSIONAL STATE 1630 0.0101
181 LIMB DEFORMITY 16 0.0101
182 GENERAL PHYSICAL HEALTH DETERIORATION 1160 0.0100
183 EXPOSURE DURING PREGNANCY 620 0.0100
184 INTENTIONAL PRODUCT USE ISSUE 872 0.0099
185 SINUSITIS 1014 0.0099
186 OVERDOSE 2132 0.0099
187 DRUG-INDUCED LIVER INJURY 309 0.0098
188 PERIPHERAL SWELLING 1515 0.0098
189 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 166 0.0097
190 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
191 EAR PAIN 184 0.0095
192 THYROXINE FREE INCREASED 6 0.0094
193 EOSINOPHIL COUNT ABNORMAL 7 0.0094
194 DEATH NEONATAL 13 0.0093
195 PERIPHERAL ARTERY THROMBOSIS 13 0.0093
196 PRECANCEROUS CELLS PRESENT 13 0.0092
197 LIVER DISORDER 406 0.0091
198 THERAPY NON-RESPONDER 407 0.0090
199 DEVELOPMENTAL DELAY 81 0.0090
200 ABDOMINAL DISCOMFORT 1502 0.0089
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 23 0.0086
202 BACK DISORDER 140 0.0086
203 FREQUENT BOWEL MOVEMENTS 229 0.0085
204 LABILE BLOOD PRESSURE 10 0.0084
205 RENAL FUNCTION TEST ABNORMAL 39 0.0084
206 NASOPHARYNGITIS 1532 0.0083
207 INFECTION 1199 0.0083
208 DEVICE RELATED THROMBOSIS 8 0.0081
209 HYPERSENSITIVITY 1500 0.0081
210 ALOPECIA 1525 0.0078
211 HEPATITIS 197 0.0077
212 MIGRAINE 721 0.0075
213 JOINT STIFFNESS 198 0.0075
214 DRUG TOLERANCE 38 0.0075
215 ANALGESIC DRUG LEVEL INCREASED 12 0.0075
216 AMNESIA 471 0.0072
217 VAGINAL DISCHARGE 73 0.0072
218 HYPOAESTHESIA 1057 0.0071
219 MOANING 8 0.0070
220 GASTROOESOPHAGEAL REFLUX DISEASE 556 0.0069
221 SPINAL FUSION SURGERY 28 0.0069
222 WEIGHT FLUCTUATION 72 0.0069
223 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
224 URINE ABNORMALITY 31 0.0068
225 OSTEOPOROTIC FRACTURE 13 0.0068
226 MEDICATION ERROR 369 0.0066
227 BLOOD CALCIUM DECREASED 74 0.0066
228 NECK PAIN 363 0.0065
229 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 110 0.0065
230 POST-TRAUMATIC STRESS DISORDER 43 0.0064
231 OTITIS MEDIA 21 0.0064
232 FOOD ALLERGY 49 0.0063
233 WEIGHT INCREASED 1415 0.0063
234 EAR INFECTION 167 0.0063
235 WITHDRAWAL SYNDROME 263 0.0063
236 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 445 0.0062
237 OSTEOPOROSIS 256 0.0062
238 PREMATURE LABOUR 35 0.0062
239 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 14 0.0061
240 DUODENAL ULCER 42 0.0059
241 DYSPEPSIA 583 0.0059
242 BLOOD PRESSURE DIASTOLIC ABNORMAL 15 0.0059
243 URTICARIA 974 0.0058
244 RESPIRATORY DISORDER 172 0.0057
245 HYPOREFLEXIA 11 0.0057
246 SINUSITIS BACTERIAL 6 0.0057
247 BONE DEMINERALISATION 6 0.0057
248 HYPERTENSION 1174 0.0055
249 MEMORY IMPAIRMENT 757 0.0055
250 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 263 0.0055
251 ORAL CANDIDIASIS 72 0.0055
252 PROCTALGIA 35 0.0054
253 MUSCULAR WEAKNESS 615 0.0054
254 ABDOMINAL PAIN UPPER 1112 0.0054
255 OESOPHAGEAL PAIN 21 0.0053
256 ARTERIOSCLEROSIS CORONARY ARTERY 35 0.0053
257 MACULAR DEGENERATION 63 0.0053
258 URINE ODOUR ABNORMAL 31 0.0053
259 HYPORESPONSIVE TO STIMULI 6 0.0051
260 POSTOPERATIVE WOUND INFECTION 34 0.0050
261 FLUID RETENTION 256 0.0050
262 OVERWEIGHT 27 0.0050
263 INFECTED CYST 6 0.0050
264 PARAESTHESIA 781 0.0050
265 ORTHOSTATIC HYPOTENSION 85 0.0049
266 DEPRESSION 1102 0.0048
267 IMMUNODEFICIENCY 71 0.0048
268 NEUTROPHIL PERCENTAGE INCREASED 6 0.0048
269 POLYP 31 0.0047
270 RECTAL HAEMORRHAGE 203 0.0047
271 ASTHMA 516 0.0046
272 INFUSION SITE DISCHARGE 8 0.0046
273 LEARNING DISORDER 11 0.0046
274 NEPHROGENIC ANAEMIA 21 0.0045
275 SPEECH DISORDER DEVELOPMENTAL 13 0.0045
276 PARAESTHESIA ORAL 65 0.0045
277 LYMPHOCYTE PERCENTAGE DECREASED 6 0.0045
278 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
279 ADVERSE EVENT 409 0.0044
280 COLITIS ULCERATIVE 198 0.0044
281 ASPHYXIA 36 0.0044
282 CONDITION AGGRAVATED 1339 0.0044
283 SEDATION 115 0.0044
284 ARTHRALGIA 1821 0.0044
285 PRODUCT USE ISSUE 811 0.0043
286 FURUNCLE 34 0.0043
287 MUSCLE SPASMS 773 0.0042
288 FOETAL EXPOSURE DURING PREGNANCY 341 0.0042
289 LYMPHOEDEMA 29 0.0042
290 BLADDER DISORDER 41 0.0041
291 ATTENTION DEFICIT HYPERACTIVITY DISORDER 17 0.0040
292 EXPOSURE VIA BREAST MILK 16 0.0040
293 ADVERSE DRUG REACTION 348 0.0039
294 SUSPECTED SUICIDE 18 0.0038
295 RASH 1672 0.0038
296 LIVEDO RETICULARIS 8 0.0038
297 ANTICHOLINERGIC SYNDROME 6 0.0038
298 SUSPECTED OFF LABEL USE 17 0.0038
299 PYREXIA 1299 0.0038
300 ATELECTASIS 36 0.0037
301 ABDOMINAL RIGIDITY 10 0.0037
302 CHEST PAIN 680 0.0037
303 UPPER RESPIRATORY TRACT INFECTION 169 0.0037
304 HYPERPARATHYROIDISM SECONDARY 9 0.0036
305 FRUSTRATION TOLERANCE DECREASED 29 0.0036
306 LABORATORY TEST ABNORMAL 105 0.0036
307 HEPATORENAL SYNDROME 6 0.0036
308 OEDEMA PERIPHERAL 433 0.0035
309 HYPOVOLAEMIC SHOCK 17 0.0035
310 COMPLETED SUICIDE 294 0.0035
311 RESPIRATORY RATE DECREASED 11 0.0035
312 POLYARTHRITIS 18 0.0034
313 PAIN 2087 0.0034
314 GAIT DISTURBANCE 649 0.0034
315 PRODUCT USE IN UNAPPROVED INDICATION 836 0.0034
316 MUSCLE SPASTICITY 41 0.0033
317 INJECTION SITE REACTION 229 0.0033
318 DECREASED APPETITE 767 0.0033
319 HAND FRACTURE 23 0.0032
320 INFUSION SITE BRUISING 7 0.0032
321 BONE DISORDER 58 0.0032
322 SACROILIITIS 6 0.0032
323 PRODUCT QUALITY ISSUE 431 0.0032
324 OXYGEN SATURATION ABNORMAL 9 0.0032
325 ECONOMIC PROBLEM 48 0.0032
326 MASS 44 0.0031
327 SUBSTANCE USE DISORDER 10 0.0031
328 PROTEIN TOTAL INCREASED 8 0.0030
329 OSTEOPENIA 45 0.0030
330 BRADYPNOEA 8 0.0030
331 FIBROSIS 9 0.0029
332 END STAGE RENAL DISEASE 53 0.0029
333 NEUTROPENIC COLITIS 6 0.0029
334 PRURITUS 1115 0.0029
335 DRUG SCREEN FALSE POSITIVE 8 0.0029
336 UNDERDOSE 211 0.0029
337 INSOMNIA 766 0.0029
338 RESPIRATORY DEPRESSION 35 0.0029
339 THYROID DISORDER 44 0.0029
340 INJECTION SITE DISCOMFORT 30 0.0028
341 ASTHENIA 1071 0.0028
342 PANCREATITIS 150 0.0028
343 HYPERNATRAEMIA 14 0.0028
344 PAIN IN EXTREMITY 826 0.0028
345 PNEUMONIA 897 0.0028
346 DRUG DIVERSION 17 0.0027
347 HYPERTRANSAMINASAEMIA 19 0.0027
348 MUSCULOSKELETAL DISCOMFORT 47 0.0027
349 BREAST MASS 18 0.0027
350 URINE ANALYSIS ABNORMAL 8 0.0027
351 DECREASED IMMUNE RESPONSIVENESS 26 0.0026
352 REBOUND ACID HYPERSECRETION 8 0.0026
353 ARTHRITIS 208 0.0026
354 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
355 FATIGUE 2032 0.0026
356 DYSPNOEA 1471 0.0026
357 BODY TEMPERATURE INCREASED 53 0.0026
358 GAMBLING DISORDER 7 0.0026
359 ANXIETY 737 0.0026
360 CHRONIC KIDNEY DISEASE 195 0.0026
361 ABDOMINAL PAIN 595 0.0026
362 RHEUMATOID NODULE 7 0.0025
363 VOMITING 1189 0.0025
364 ABDOMINAL DISTENSION 263 0.0025
365 SLEEP APNOEA SYNDROME 48 0.0025
366 WHITE BLOOD CELL COUNT INCREASED 95 0.0025
367 MALAISE 1072 0.0024
368 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
369 FEELING HOT 149 0.0024
370 WEIGHT DECREASED 664 0.0024
371 ASPIRATION 26 0.0024
372 KLEBSIELLA INFECTION 12 0.0024
373 ARTHRITIS INFECTIVE 11 0.0024
374 ANHEDONIA 62 0.0024
375 POST PROCEDURAL INFECTION 19 0.0023
376 BLOOD PRESSURE FLUCTUATION 56 0.0023
377 AORTIC ARTERIOSCLEROSIS 6 0.0023
378 GANGRENE 14 0.0023
379 COLITIS 88 0.0023
380 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
381 IRITIS 7 0.0023
382 VISUAL IMPAIRMENT 282 0.0023
383 DIZZINESS 1133 0.0023
384 DEPRESSED LEVEL OF CONSCIOUSNESS 89 0.0022
385 NEPHROPATHY 21 0.0022
386 DEFORMITY 21 0.0022
387 SKIN PAPILLOMA 9 0.0022
388 STEATORRHOEA 6 0.0022
389 HYPERVOLAEMIA 11 0.0022
390 BRONCHITIS 162 0.0022
391 CORONARY ARTERY STENOSIS 11 0.0022
392 PERIPHERAL COLDNESS 30 0.0022
393 DYSLIPIDAEMIA 11 0.0022
394 PSORIASIS 281 0.0021
395 RENAL CYST 17 0.0021
396 NEPHROLITHIASIS 98 0.0021
397 SCOLIOSIS 13 0.0021
398 TOXICITY TO VARIOUS AGENTS 353 0.0021
399 FIBULA FRACTURE 6 0.0021
400 INTENTIONAL PRODUCT MISUSE 181 0.0021
401 HEADACHE 1293 0.0021
402 HEPATIC CYST 7 0.0021
403 COGNITIVE DISORDER 96 0.0021
404 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
405 HYPOPNOEA 7 0.0020
406 DIARRHOEA 1289 0.0020
407 BRAIN INJURY 20 0.0020
408 SWOLLEN TONGUE 62 0.0020
409 PROCEDURAL PAIN 55 0.0020
410 NECROSIS 11 0.0020
411 ABDOMINAL HERNIA 9 0.0020
412 ACIDOSIS 15 0.0020
413 GALLBLADDER DISORDER 35 0.0020
414 OFF LABEL USE 1708 0.0019
415 TOOTH LOSS 40 0.0019
416 PARTIAL SEIZURES 10 0.0019
417 OVARIAN CYST 19 0.0019
418 HEART RATE DECREASED 66 0.0019
419 ORAL PAIN 42 0.0019
420 EXPOSURE TO TOXIC AGENT 6 0.0019
421 SHOULDER OPERATION 8 0.0019
422 TEARFULNESS 8 0.0019
423 FOOT FRACTURE 35 0.0018
424 LYMPHOCYTE COUNT INCREASED 6 0.0018
425 PRODUCT PRESCRIBING ISSUE 40 0.0018
426 GROIN PAIN 16 0.0018
427 APPETITE DISORDER 12 0.0018
428 RHINITIS ALLERGIC 8 0.0018
429 ANXIETY DISORDER 6 0.0018
430 TACHYCARDIA 157 0.0018
431 INFUSION SITE SWELLING 11 0.0017
432 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
433 FULL BLOOD COUNT DECREASED 35 0.0017
434 ADRENAL INSUFFICIENCY 21 0.0017
435 HEART RATE IRREGULAR 39 0.0017
436 SPINAL PAIN 20 0.0017
437 MULTIPLE FRACTURES 28 0.0017
438 ARTERIOSCLEROSIS 16 0.0017
439 SPINAL STENOSIS 7 0.0017
440 EATING DISORDER 36 0.0017
441 ANAL FISTULA 9 0.0017
442 BIPOLAR DISORDER 18 0.0017
443 LIMB DISCOMFORT 51 0.0016
444 PURULENT DISCHARGE 7 0.0016
445 INTESTINAL ISCHAEMIA 9 0.0016
446 CARDIO-RESPIRATORY ARREST 68 0.0016
447 DRUG DEPENDENCE 261 0.0016
448 DRUG ABUSE 135 0.0016
449 SUBSTANCE ABUSE 13 0.0016
450 CONSTIPATION 347 0.0016
451 HYPERHIDROSIS 203 0.0016
452 NAUSEA 1247 0.0016
453 BONE DENSITY DECREASED 49 0.0016
454 NEURALGIA 38 0.0016
455 ANKLE FRACTURE 24 0.0015
456 POOR VENOUS ACCESS 16 0.0015
457 DRUG INEFFECTIVE 2030 0.0015
458 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
459 THROMBOCYTOPENIA 170 0.0015
460 MENTAL DISORDER 66 0.0015
461 DERMATITIS ALLERGIC 19 0.0015
462 NIGHTMARE 52 0.0015
463 ROTATOR CUFF SYNDROME 19 0.0015
464 HAEMATOCHEZIA 81 0.0015
465 HYPERAESTHESIA 12 0.0015
466 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
467 ULCER 23 0.0014
468 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
469 FALL 480 0.0014
470 INCORRECT PRODUCT ADMINISTRATION DURATION 31 0.0014
471 KNEE OPERATION 14 0.0014
472 GASTRIC ULCER 27 0.0014
473 RESPIRATORY ARREST 39 0.0014
474 SEASONAL ALLERGY 20 0.0014
475 THERMAL BURN 10 0.0014
476 HEPATITIS C 17 0.0014
477 LIMB INJURY 38 0.0014
478 VEIN DISORDER 7 0.0014
479 INFUSION SITE PAIN 18 0.0014
480 HEPATIC STEATOSIS 26 0.0014
481 PATHOLOGICAL FRACTURE 7 0.0014
482 HYPOVOLAEMIA 8 0.0014
483 ANKYLOSING SPONDYLITIS 18 0.0014
484 CARPAL TUNNEL SYNDROME 19 0.0014
485 RESPIRATORY RATE INCREASED 12 0.0014
486 CYSTITIS 43 0.0013
487 URINARY INCONTINENCE 40 0.0013
488 SKIN REACTION 19 0.0013
489 ACCIDENTAL OVERDOSE 49 0.0013
490 THERAPEUTIC RESPONSE DECREASED 81 0.0013
491 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
492 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
493 JAUNDICE 35 0.0013
494 GINGIVITIS 7 0.0013
495 ANGIOEDEMA 57 0.0013
496 BALANCE DISORDER 111 0.0013
497 TIBIA FRACTURE 6 0.0013
498 HYPOXIA 45 0.0013
499 RASH ERYTHEMATOUS 61 0.0013
500 DIVERTICULUM 9 0.0013
501 ACUTE HEPATIC FAILURE 17 0.0012
502 VITAMIN D DEFICIENCY 12 0.0012
503 BACK PAIN 285 0.0012
504 HOSPITALISATION 188 0.0012
505 SPRUE-LIKE ENTEROPATHY 6 0.0012
506 MOUTH SWELLING 7 0.0012
507 NEEDLE ISSUE 35 0.0012
508 DYSURIA 44 0.0012
509 DIVERTICULITIS 33 0.0012
510 FEELING COLD 33 0.0012
511 TOOTH ABSCESS 12 0.0012
512 DENTAL CARIES 13 0.0012
513 IMPAIRED GASTRIC EMPTYING 16 0.0012
514 PERIPHERAL VASCULAR DISORDER 6 0.0012
515 CONCUSSION 9 0.0012
516 THERAPY PARTIAL RESPONDER 18 0.0012
517 INGUINAL HERNIA 7 0.0011
518 DYSPHONIA 67 0.0011
519 SEROTONIN SYNDROME 22 0.0011
520 BLOOD LACTIC ACID INCREASED 6 0.0011
521 SPINAL OPERATION 14 0.0011
522 EMOTIONAL DISTRESS 137 0.0011
523 PURPURA 10 0.0011
524 INFUSION SITE EXTRAVASATION 7 0.0011
525 BODY HEIGHT DECREASED 12 0.0011
526 POST PROCEDURAL HAEMORRHAGE 13 0.0011
527 RESPIRATORY TRACT INFECTION 29 0.0011
528 STRESS FRACTURE 6 0.0011
529 SEXUAL DYSFUNCTION 13 0.0011
530 GASTROENTERITIS VIRAL 20 0.0011
531 MUSCULOSKELETAL CHEST PAIN 17 0.0011
532 SPINAL FRACTURE 22 0.0011
533 MAJOR DEPRESSION 8 0.0011
534 ANGINA UNSTABLE 7 0.0011
535 HEPATITIS ACUTE 7 0.0011
536 TENDON DISORDER 7 0.0011
537 RIB FRACTURE 22 0.0011
538 RENAL FAILURE 142 0.0011
539 INFUSION SITE ERYTHEMA 9 0.0011
540 BEDRIDDEN 14 0.0011
541 PERIORBITAL SWELLING 6 0.0011
542 CARDIOMEGALY 13 0.0011
543 SMALL INTESTINAL OBSTRUCTION 13 0.0011
544 SPINAL DISORDER 10 0.0011
545 DERMATITIS CONTACT 12 0.0011
546 TROPONIN INCREASED 8 0.0011
547 MUSCULOSKELETAL DISORDER 20 0.0010
548 RESTLESS LEGS SYNDROME 19 0.0010
549 TINNITUS 48 0.0010
550 CARDIAC MURMUR 9 0.0010
551 ILLNESS 107 0.0010
552 DEMENTIA 29 0.0010
553 HYPOTENSION 208 0.0010
554 TOOTH DISORDER 23 0.0010
555 LOCALISED INFECTION 25 0.0010
556 RETCHING 22 0.0010
557 URINE OUTPUT DECREASED 9 0.0010
558 DYSSTASIA 30 0.0010
559 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
560 HEREDITARY ANGIOEDEMA 11 0.0010
561 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
562 DEATH 878 0.0010
563 JOINT EFFUSION 7 0.0010
564 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
565 SKIN LACERATION 11 0.0010
566 LIGAMENT SPRAIN 10 0.0010
567 SINUS HEADACHE 6 0.0010
568 HIATUS HERNIA 13 0.0010
569 FEMUR FRACTURE 31 0.0010
570 LEUKOPENIA 50 0.0010
571 BONE LOSS 15 0.0010
572 MIOSIS 8 0.0010
573 GASTRITIS 26 0.0010
574 HERNIA 19 0.0010
575 ACUTE KIDNEY INJURY 150 0.0010
576 EYE INFECTION 11 0.0010
577 INJECTION SITE MASS 36 0.0010
578 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
579 MITRAL VALVE INCOMPETENCE 11 0.0010
580 METABOLIC ACIDOSIS 31 0.0010
581 TREATMENT NONCOMPLIANCE 53 0.0010
582 MYOCARDIAL ISCHAEMIA 11 0.0010
583 MENSTRUAL DISORDER 8 0.0010
584 PALPITATIONS 113 0.0010
585 DISTURBANCE IN ATTENTION 52 0.0010
586 PRE-EXISTING CONDITION IMPROVED 6 0.0010
587 SUICIDE ATTEMPT 58 0.0010
588 SOMNOLENCE 191 0.0009
589 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
590 CEREBRAL DISORDER 7 0.0009
591 CHOLELITHIASIS 31 0.0009
592 RENAL INJURY 28 0.0009
593 SPLENOMEGALY 11 0.0009
594 JOINT INJURY 20 0.0009
595 MYDRIASIS 12 0.0009
596 APHONIA 13 0.0009
597 CORONARY ARTERY DISEASE 28 0.0009
598 HERPES SIMPLEX 6 0.0009
599 RASH PRURITIC 50 0.0009
600 HERPES ZOSTER 53 0.0009
601 SWELLING FACE 60 0.0009
602 PHARYNGEAL SWELLING 9 0.0009
603 SINUS TACHYCARDIA 13 0.0009
604 BODY TEMPERATURE DECREASED 9 0.0009
605 HYPOKALAEMIA 42 0.0009
606 MOOD SWINGS 29 0.0009
607 DEHYDRATION 121 0.0009
608 HALLUCINATION 68 0.0009
609 MULTIPLE ALLERGIES 7 0.0009
610 EMPHYSEMA 9 0.0009
611 DIABETES MELLITUS 68 0.0009
612 LOSS OF LIBIDO 8 0.0009
613 GENERALISED OEDEMA 11 0.0009
614 HAEMOGLOBIN DECREASED 90 0.0009
615 LUNG NEOPLASM MALIGNANT 36 0.0009
616 ECCHYMOSIS 6 0.0009
617 ANGINA PECTORIS 25 0.0009
618 INCREASED TENDENCY TO BRUISE 8 0.0009
619 DYSPHAGIA 82 0.0009
620 BREAST CANCER STAGE I 8 0.0009
621 ELECTROLYTE IMBALANCE 10 0.0009
622 BLOOD PRESSURE ABNORMAL 17 0.0009
623 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
624 BONE PAIN 50 0.0009
625 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
626 BLOOD PRESSURE INCREASED 128 0.0008
627 TOOTH INFECTION 11 0.0008
628 DECREASED ACTIVITY 9 0.0008
629 WRIST FRACTURE 10 0.0008
630 DRUG USE DISORDER 7 0.0008
631 SOPOR 11 0.0008
632 HAEMATEMESIS 21 0.0008
633 PULMONARY THROMBOSIS 9 0.0008
634 ERYTHEMA 169 0.0008
635 HAEMORRHOIDS 16 0.0008
636 SKIN HYPERPIGMENTATION 7 0.0008
637 BLOOD GLUCOSE DECREASED 39 0.0008
638 CYST 10 0.0008
639 HYPONATRAEMIA 45 0.0008
640 INFLUENZA 89 0.0008
641 SPINAL OSTEOARTHRITIS 7 0.0008
642 CELLULITIS 40 0.0008
643 METASTASES TO BONE 13 0.0008
644 BLOOD URINE PRESENT 15 0.0008
645 SUICIDAL IDEATION 72 0.0008
646 INSURANCE ISSUE 12 0.0008
647 NEUTROPHIL COUNT INCREASED 8 0.0008
648 EUPHORIC MOOD 8 0.0008
649 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
650 METASTASES TO LUNG 9 0.0008
651 DRUG INTERACTION 123 0.0008
652 SKIN ULCER 20 0.0008
653 RENAL DISORDER 36 0.0008
654 PELVIC FRACTURE 6 0.0008
655 OPTIC NEURITIS 7 0.0008
656 TENDERNESS 8 0.0008
657 HYPERSOMNIA 22 0.0008
658 PETECHIAE 8 0.0008
659 NODULE 10 0.0008
660 ANAEMIA 146 0.0008
661 TRANSFUSION 8 0.0008
662 AFFECTIVE DISORDER 6 0.0008
663 URINARY TRACT INFECTION 130 0.0008
664 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
665 PULMONARY OEDEMA 34 0.0008
666 DRUG SCREEN POSITIVE 6 0.0008
667 PULMONARY CONGESTION 10 0.0008
668 NERVE COMPRESSION 7 0.0008
669 SCRATCH 8 0.0008
670 HEAD INJURY 24 0.0008
671 ATAXIA 9 0.0008
672 HYPOKINESIA 11 0.0008
673 SINUS DISORDER 15 0.0008
674 INCONTINENCE 8 0.0008
675 PANCREATITIS ACUTE 17 0.0008
676 BLOOD ALBUMIN DECREASED 6 0.0008
677 HYPERLIPIDAEMIA 9 0.0008
678 ATRIAL FLUTTER 6 0.0008
679 MIDDLE INSOMNIA 14 0.0007
680 BLOOD DISORDER 6 0.0007
681 BREAST CANCER METASTATIC 8 0.0007
682 RHINITIS 6 0.0007
683 PERICARDIAL EFFUSION 17 0.0007
684 PALLOR 20 0.0007
685 DRUG ERUPTION 13 0.0007
686 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
687 GASTRIC DISORDER 25 0.0007
688 ATRIAL FIBRILLATION 70 0.0007
689 OSTEOMYELITIS 13 0.0007
690 DYSPNOEA EXERTIONAL 27 0.0007
691 MALNUTRITION 8 0.0007
692 PHARYNGEAL OEDEMA 11 0.0007
693 PRODUCTIVE COUGH 34 0.0007
694 HOSPICE CARE 7 0.0007
695 AGITATION 52 0.0007
696 BRAIN FOG 11 0.0007
697 IMPAIRED WORK ABILITY 15 0.0007
698 PREMATURE BABY 21 0.0007
699 HEPATIC FAILURE 21 0.0007
700 FAECES DISCOLOURED 15 0.0007
701 PLATELET COUNT INCREASED 9 0.0007
702 MENTAL STATUS CHANGES 19 0.0007
703 HIP FRACTURE 22 0.0007
704 CARDIAC ARREST 56 0.0007
705 GLAUCOMA 13 0.0007
706 HEPATOTOXICITY 15 0.0007
707 HYPOACUSIS 29 0.0007
708 CARDIAC DISORDER 63 0.0007
709 QUALITY OF LIFE DECREASED 9 0.0007
710 ACCIDENT 8 0.0007
711 OSTEONECROSIS 22 0.0007
712 EYE DISORDER 22 0.0007
713 MUSCLE RIGIDITY 8 0.0007
714 ANAL INCONTINENCE 6 0.0007
715 MENTAL IMPAIRMENT 16 0.0007
716 COUGH 185 0.0007
717 SKIN DISORDER 22 0.0007
718 OXYGEN SATURATION DECREASED 37 0.0007
719 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
720 SEIZURE 75 0.0006
721 INJECTION SITE EXTRAVASATION 8 0.0006
722 NEUROPATHY PERIPHERAL 61 0.0006
723 NERVOUS SYSTEM DISORDER 20 0.0006
724 CARDIAC FAILURE 51 0.0006
725 FRACTURE 12 0.0006
726 POISONING DELIBERATE 6 0.0006
727 SPUTUM DISCOLOURED 6 0.0006
728 SKIN DISCOLOURATION 29 0.0006
729 VENTRICULAR FIBRILLATION 7 0.0006
730 NERVE INJURY 7 0.0006
731 IMPAIRED QUALITY OF LIFE 9 0.0006
732 METASTASES TO LIVER 11 0.0006
733 LETHARGY 36 0.0006
734 DEPRESSED MOOD 33 0.0006
735 COLD SWEAT 11 0.0006
736 SKIN INFECTION 7 0.0006
737 SENSORY DISTURBANCE 10 0.0006
738 MOVEMENT DISORDER 20 0.0006
739 LYMPHADENOPATHY 22 0.0006
740 APATHY 9 0.0006
741 OROPHARYNGEAL PAIN 57 0.0006
742 INTESTINAL OBSTRUCTION 23 0.0006
743 COMA 29 0.0006
744 IMMUNE SYSTEM DISORDER 8 0.0006
745 POOR QUALITY SLEEP 13 0.0006
746 PANIC ATTACK 22 0.0006
747 VIRAL INFECTION 20 0.0006
748 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
749 AGGRESSION 30 0.0006
750 DEVICE DISLOCATION 26 0.0006
751 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
752 PRODUCT ADMINISTRATION ERROR 12 0.0006
753 COVID-19 PNEUMONIA 7 0.0006
754 HYPOTHERMIA 6 0.0006
755 THINKING ABNORMAL 11 0.0006
756 BACTERIAL INFECTION 11 0.0006
757 SLUGGISHNESS 6 0.0006
758 DRUG WITHDRAWAL SYNDROME 51 0.0006
759 DISORIENTATION 23 0.0006
760 SKELETAL INJURY 6 0.0006
761 THROAT IRRITATION 26 0.0006
762 DELUSION 9 0.0006
763 NASAL CONGESTION 34 0.0006
764 PULMONARY HYPERTENSION 12 0.0006
765 MUCOSAL INFLAMMATION 15 0.0006
766 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
767 FEELING ABNORMAL 137 0.0006
768 RESPIRATORY TRACT CONGESTION 9 0.0006
769 CHEST DISCOMFORT 58 0.0006
770 RENAL PAIN 6 0.0006
771 HEAD DISCOMFORT 10 0.0006
772 PHARYNGITIS 7 0.0006
773 HEPATOCELLULAR INJURY 8 0.0006
774 CHOKING 11 0.0006
775 BRONCHOSPASM 8 0.0006
776 MYOCARDIAL INFARCTION 97 0.0006
777 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29 0.0006
778 RHABDOMYOLYSIS 23 0.0006
779 OESOPHAGITIS 6 0.0005
780 HEPATIC CYTOLYSIS 7 0.0005
781 GASTROINTESTINAL PAIN 6 0.0005
782 HAEMORRHAGE 57 0.0005
783 PHOTOSENSITIVITY REACTION 9 0.0005
784 PULMONARY MASS 8 0.0005
785 NERVOUSNESS 28 0.0005
786 HOT FLUSH 40 0.0005
787 PLEURAL EFFUSION 32 0.0005
788 INTERNAL HAEMORRHAGE 6 0.0005
789 VISION BLURRED 72 0.0005
790 PARANOIA 9 0.0005
791 GASTRIC HAEMORRHAGE 6 0.0005
792 LIVER FUNCTION TEST ABNORMAL 15 0.0005
793 HYPOGLYCAEMIA 25 0.0005
794 HEART RATE INCREASED 51 0.0005
795 INJECTION SITE BRUISING 41 0.0005
796 GINGIVAL BLEEDING 7 0.0005
797 FUNGAL INFECTION 17 0.0005
798 KIDNEY INFECTION 10 0.0005
799 BLOOD IRON DECREASED 6 0.0005
800 HAEMATOCRIT DECREASED 10 0.0005
801 THIRST 9 0.0005
802 POLLAKIURIA 21 0.0005
803 ABSCESS 8 0.0005
804 TREMOR 83 0.0005
805 LEUKOCYTOSIS 9 0.0005
806 PAIN IN JAW 14 0.0005
807 MUSCLE TIGHTNESS 8 0.0005
808 RESPIRATORY FAILURE 36 0.0005
809 SYNCOPE 49 0.0005
810 CONJUNCTIVITIS 9 0.0005
811 LOSS OF CONSCIOUSNESS 62 0.0005
812 ILEUS 6 0.0005
813 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
814 TOOTH EXTRACTION 6 0.0005
815 BLOOD PRESSURE DECREASED 32 0.0005
816 COAGULOPATHY 8 0.0005
817 SECRETION DISCHARGE 6 0.0005
818 POISONING 6 0.0005
819 MYALGIA 81 0.0005
820 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
821 SKIN LESION 13 0.0005
822 CHILLS 55 0.0005
823 SCAR 8 0.0005
824 NEOPLASM MALIGNANT 31 0.0005
825 SURGERY 27 0.0005
826 VERTIGO 28 0.0005
827 FLATULENCE 26 0.0005
828 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
829 LYMPHOCYTE COUNT DECREASED 8 0.0005
830 TENDONITIS 7 0.0005
831 UPPER LIMB FRACTURE 9 0.0005
832 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
833 CARDIAC FAILURE CONGESTIVE 36 0.0004
834 ENCEPHALOPATHY 11 0.0004
835 MALIGNANT MELANOMA 6 0.0004
836 GOUT 8 0.0004
837 THROAT TIGHTNESS 12 0.0004
838 RESTLESSNESS 16 0.0004
839 RESPIRATORY DISTRESS 12 0.0004
840 ANAPHYLACTIC REACTION 24 0.0004
841 BLOOD GLUCOSE ABNORMAL 8 0.0004
842 BLOOD POTASSIUM DECREASED 13 0.0004
843 HYPOPHAGIA 11 0.0004
844 HAEMOPTYSIS 12 0.0004
845 COORDINATION ABNORMAL 6 0.0004
846 EYE SWELLING 16 0.0004
847 UNRESPONSIVE TO STIMULI 11 0.0004
848 DRUG ADMINISTRATION ERROR 13 0.0004
849 UNEVALUABLE EVENT 32 0.0004
850 CATARACT 25 0.0004
851 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
852 POST PROCEDURAL COMPLICATION 8 0.0004
853 EPISTAXIS 31 0.0004
854 BLOOD CREATININE INCREASED 27 0.0004
855 ERUCTATION 8 0.0004
856 THROMBOSIS 33 0.0004
857 HYPOTHYROIDISM 13 0.0004
858 ACUTE MYOCARDIAL INFARCTION 12 0.0004
859 CARDIOMYOPATHY 6 0.0004
860 TRANSAMINASES INCREASED 9 0.0004
861 RHINORRHOEA 26 0.0004
862 CEREBROVASCULAR ACCIDENT 68 0.0004
863 AGEUSIA 10 0.0004
864 PNEUMONIA ASPIRATION 10 0.0004
865 BURNING SENSATION 28 0.0004
866 DYSARTHRIA 15 0.0004
867 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
868 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
869 INTENTIONAL SELF-INJURY 8 0.0004
870 BLOOD COUNT ABNORMAL 6 0.0004
871 PLATELET COUNT DECREASED 42 0.0004
872 DYSKINESIA 16 0.0004
873 BLINDNESS 16 0.0004
874 EYE PAIN 22 0.0004
875 INTENTIONAL OVERDOSE 25 0.0004
876 ERECTILE DYSFUNCTION 10 0.0004
877 EMOTIONAL DISORDER 12 0.0004
878 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
879 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
880 DEEP VEIN THROMBOSIS 25 0.0004
881 ANGER 13 0.0004
882 DEAFNESS 10 0.0004
883 DERMATITIS 8 0.0004
884 MOUTH ULCERATION 8 0.0004
885 PNEUMOTHORAX 6 0.0004
886 BRADYCARDIA 20 0.0004
887 NEOPLASM PROGRESSION 13 0.0004
888 PRESYNCOPE 9 0.0004
889 RENAL IMPAIRMENT 31 0.0004
890 PROTEINURIA 7 0.0004
891 SEPSIS 41 0.0004
892 ACUTE RESPIRATORY FAILURE 7 0.0004
893 OSTEONECROSIS OF JAW 9 0.0004
894 DRUG LEVEL INCREASED 6 0.0004
895 DYSTONIA 7 0.0004
896 URINARY RETENTION 12 0.0004
897 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
898 PULMONARY EMBOLISM 34 0.0004
899 CANDIDA INFECTION 6 0.0004
900 CARDIOVASCULAR DISORDER 9 0.0004
901 CHROMATURIA 8 0.0004
902 INTENTIONAL DOSE OMISSION 10 0.0004
903 IRRITABILITY 21 0.0003
904 COVID-19 61 0.0003
905 HAEMATOMA 9 0.0003
906 EOSINOPHILIA 6 0.0003
907 STAPHYLOCOCCAL INFECTION 11 0.0003
908 SKIN EXFOLIATION 28 0.0003
909 PNEUMONITIS 9 0.0003
910 DRUG EFFECT INCOMPLETE 12 0.0003
911 PELVIC PAIN 6 0.0003
912 MOOD ALTERED 9 0.0003
913 HAEMATURIA 11 0.0003
914 BLOOD SODIUM DECREASED 6 0.0003
915 MELAENA 7 0.0003
916 HYPOCALCAEMIA 6 0.0003
917 STEVENS-JOHNSON SYNDROME 7 0.0003
918 LACTIC ACIDOSIS 10 0.0003
919 PRODUCT AVAILABILITY ISSUE 7 0.0003
920 SKIN FISSURES 6 0.0003
921 PRODUCT DOSE OMISSION 20 0.0003
922 PSYCHOTIC DISORDER 9 0.0003
923 LIP SWELLING 10 0.0003
924 NO ADVERSE EVENT 54 0.0003
925 LACRIMATION INCREASED 9 0.0003
926 FEEDING DISORDER 6 0.0003
927 MULTIPLE SCLEROSIS 14 0.0003
928 INFLUENZA LIKE ILLNESS 24 0.0003
929 HEPATIC CANCER 7 0.0003
930 BREAST CANCER 27 0.0003
931 SPEECH DISORDER 15 0.0003
932 HALLUCINATION, VISUAL 6 0.0003
933 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
934 PRODUCT DOSE OMISSION ISSUE 83 0.0003
935 DRY EYE 14 0.0003
936 ABNORMAL BEHAVIOUR 11 0.0003
937 ABDOMINAL PAIN LOWER 7 0.0003
938 ABORTION SPONTANEOUS 11 0.0003
939 HYPERGLYCAEMIA 10 0.0003
940 DEVICE MALFUNCTION 19 0.0003
941 RASH MACULO-PAPULAR 6 0.0003
942 DIPLOPIA 7 0.0003
943 SNEEZING 6 0.0003
944 FEAR 7 0.0003
945 PAIN OF SKIN 7 0.0003
946 HYPERKALAEMIA 9 0.0003
947 FEBRILE NEUTROPENIA 17 0.0003
948 FLUSHING 26 0.0003
949 DYSGEUSIA 19 0.0003
950 ARRHYTHMIA 12 0.0003
951 CRYING 9 0.0002
952 DRUG EFFECT DECREASED 13 0.0002
953 ASCITES 7 0.0002
954 THERAPY INTERRUPTED 17 0.0002
955 APHASIA 7 0.0002
956 PRODUCT SUBSTITUTION ISSUE 13 0.0002
957 DRY SKIN 30 0.0002
958 BREAST CANCER FEMALE 6 0.0002
959 INJECTION SITE SWELLING 17 0.0002
960 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
961 BLOOD GLUCOSE INCREASED 41 0.0002
962 INJECTION SITE PAIN 65 0.0002
963 VISUAL ACUITY REDUCED 7 0.0002
964 OCULAR HYPERAEMIA 10 0.0002
965 ECZEMA 11 0.0002
966 RED BLOOD CELL COUNT DECREASED 6 0.0002
967 SEPTIC SHOCK 9 0.0002
968 RASH MACULAR 7 0.0002
969 CEREBRAL HAEMORRHAGE 7 0.0002
970 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
971 DISEASE RECURRENCE 9 0.0002
972 RENAL CANCER 9 0.0002
973 EXPIRED PRODUCT ADMINISTERED 6 0.0002
974 PLASMA CELL MYELOMA 7 0.0002
975 EYE PRURITUS 6 0.0002
976 NEUTROPENIA 24 0.0002
977 THERAPY CESSATION 9 0.0002
978 INCORRECT DOSE ADMINISTERED 40 0.0002
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
980 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
981 RENAL FAILURE ACUTE 7 0.0002
982 DRUG DOSE OMISSION 24 0.0001
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
984 INJECTION SITE PRURITUS 9 0.0001
985 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
986 ACNE 10 0.0001
987 INTERSTITIAL LUNG DISEASE 6 0.0001
988 DISEASE PROGRESSION 12 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
990 PROSTATE CANCER 7 0.0001
991 INJECTION SITE ERYTHEMA 10 0.0001
992 DEVICE ISSUE 7 0.0001